Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,198 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study.
Amorim S, Stathis A, Gleeson M, Iyengar S, Magarotto V, Leleu X, Morschhauser F, Karlin L, Broussais F, Rezai K, Herait P, Kahatt C, Lokiec F, Salles G, Facon T, Palumbo A, Cunningham D, Zucca E, Thieblemont C. Amorim S, et al. Among authors: iyengar s. Lancet Haematol. 2016 Apr;3(4):e196-204. doi: 10.1016/S2352-3026(16)00021-1. Epub 2016 Mar 18. Lancet Haematol. 2016. PMID: 27063978 Clinical Trial.
Focal splenic lesions in indolent B-NHL: association with high grade transformation and safe percutaneous biopsy.
Mir F, Wilding C, Mcaddy N, Butterfield N, Sena L, Thompson S, Mitra I, Mohammed K, Vroobel K, Attygalle A, Chau I, Cunningham D, Dearden C, El-Sharkawi D, Fotiadis N, Wotherspoon A, Sharma B, Iyengar S. Mir F, et al. Among authors: iyengar s. Br J Haematol. 2020 May;189(4):e157-e160. doi: 10.1111/bjh.16580. Epub 2020 Mar 20. Br J Haematol. 2020. PMID: 32196643 Free article. No abstract available.
LyRIC indeterminate response and Immune-mediated pseudoprogression of diffuse large B-cell lymphoma following polatuzumab-based salvage therapy.
Lee ATJ, Attygale AD, Sharma RK, Iyengar S, El-Sharkawi D, Chau I, Vroobel KM, Fotiadis N, Khan N, Butterfield N, Wotherspoon A, Cunningham D, Sharma B. Lee ATJ, et al. Among authors: iyengar s. Br J Haematol. 2020 Jun;189(6):e248-e251. doi: 10.1111/bjh.16679. Epub 2020 Apr 27. Br J Haematol. 2020. PMID: 32342503 Free article. No abstract available.
Early interval and serial positron emission tomography-computed tomography (PET-CT) after an indeterminate response defined by a PET scored 4 on the Deauville scale in lymphoma.
Kumar R, Hujairi N, Mohammed K, Attygalle A, Alexander E, Chau I, Cunningham D, Iyengar S, El-Sharkawi D, Sharma B. Kumar R, et al. Among authors: iyengar s. Br J Haematol. 2020 Sep;190(6):e357-e362. doi: 10.1111/bjh.16919. Epub 2020 Jul 8. Br J Haematol. 2020. PMID: 32643153 Free article. No abstract available.
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.
Scarfò L, Chatzikonstantinou T, Rigolin GM, Quaresmini G, Motta M, Vitale C, Garcia-Marco JA, Hernández-Rivas JÁ, Mirás F, Baile M, Marquet J, Niemann CU, Reda G, Munir T, Gimeno E, Marchetti M, Quaglia FM, Varettoni M, Delgado J, Iyengar S, Janssens A, Marasca R, Ferrari A, Cuéllar-García C, Itchaki G, Špaček M, De Paoli L, Laurenti L, Levin MD, Lista E, Mauro FR, Šimkovič M, Van Der Spek E, Vandenberghe E, Trentin L, Wasik-Szczepanek E, Ruchlemer R, Bron D, De Paolis MR, Del Poeta G, Farina L, Foglietta M, Gentile M, Herishanu Y, Herold T, Jaksic O, Kater AP, Kersting S, Malerba L, Orsucci L, Popov VM, Sportoletti P, Yassin M, Pocali B, Barna G, Chiarenza A, Dos Santos G, Nikitin E, Andres M, Dimou M, Doubek M, Enrico A, Hakobyan Y, Kalashnikova O, Ortiz Pareja M, Papaioannou M, Rossi D, Shah N, Shrestha A, Stanca O, Stavroyianni N, Strugov V, Tam C, Zdrenghea M, Coscia M, Stamatopoulos K, Rossi G, Rambaldi A, Montserrat E, Foà R, Cuneo A, Ghia P. Scarfò L, et al. Among authors: iyengar s. Leukemia. 2020 Sep;34(9):2354-2363. doi: 10.1038/s41375-020-0959-x. Epub 2020 Jul 9. Leukemia. 2020. PMID: 32647324 Free PMC article.
Current and future best practice in imaging, staging, and response assessment for Non-Hodgkin's lymphomas: the Specialist Integrated Haematological Malignancy Imaging Reporting (SIHMIR) paradigm shift.
Zafar S, Sharma RK, Cunningham J, Mahalingam P, Attygalle AD, Khan N, Cunningham D, El-Sharkawi D, Iyengar S, Sharma B. Zafar S, et al. Among authors: iyengar s. Clin Radiol. 2021 May;76(5):391.e1-391.e18. doi: 10.1016/j.crad.2020.12.022. Epub 2021 Feb 10. Clin Radiol. 2021. PMID: 33579517 Review.
Are treatment response assessment maps (TRAMs) and 18 F-choline positron emission tomography the future of central nervous system lymphoma imaging?
Kowa JY, Millard T, Goldman A, Sharma RK, Attygalle A, Mahalingam P, Marshall K, Welsh L, Li S, Mackinnon A, Rich P, Nicholson E, Iyengar S, El-Sharkawi D, Chau I, Cunningham D, Sharma B. Kowa JY, et al. Among authors: iyengar s. Br J Haematol. 2021 Oct;195(1):e116-e119. doi: 10.1111/bjh.17632. Epub 2021 Jun 9. Br J Haematol. 2021. PMID: 34109610 No abstract available.
1,198 results